Physician profile
Arnold Good
NPI 1336180835
$762.11
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $289 · 2020: $298 · 2021: $175.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $229.45 | 2019-2020 | |
| Medtronic, INC. | $148.43 | 2021 | |
| Boston Scientific Corporation | $141.75 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $119.80 | 2019-2020 | |
| Cardiovascular Systems INC. | $39.85 | 2019 | |
| Biosense Webster, INC. | $16.50 | 2020 | |
| Preventice Services, LLC | $15.25 | 2019 | |
| Janssen Pharmaceuticals, INC | $13.42 | 2019 | |
| Sanofi-Aventis U.S. LLC | $12.93 | 2019 | |
| Medtronic Vascular, INC. | $12.70 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $12.03 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arnold Good listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.